Advertisement PBR Staff Writer, Author at Pharmaceutical Business review - Page 3078 of 4440
Pharmaceutical Business review is using cookies

ContinueLearn More
Close
 

All articles by  

Natus prices public offer at $19.50

Natus has also granted the underwriters a 30-day option to purchase up to an additional 600,000 shares of its common stock to cover over-allotments, if any. The offering

Allos prices public offer at $5.64

The closing of the offering is expected to take place on May 29, 2008, subject to the satisfaction of customary closing conditions. The company has granted the underwriters

Cook granted approval for aortic endovascular graft

The state-of-the-art aortic endograft is designed for thoracic endovascular aortic repair (TEVAR), a minimally invasive alternative to traditional, open surgery. The Zenith TX2 is indicated to treat patients

Dor establishes new office in UK

The new Dor UK office gives Dor a presence in the EU to better facilitate the Named Patient Access program that will be administered by IDIS, also based

Cigna wins health care contract

New Cigna members from the State of Georgia will be able to receive in-patient and out-patient services from an expanded and comprehensive network inclusive of 147 hospitals and